Influenza is primarily diagnosed clinically. Based on the presentation of symptoms, clinicians make a diagnosis and provide the appropriate...
BD Veritor Plus Viral Test
The BD Veritor Plus is a CLIA-waived office-based rapid antigen detection testing device. It has the ability to test multiple common upper respiratory infections including Flu A and B, Group A Strep, RSV (respiratory syncytial virus) and SARS-CoV-2 used to detect the coronavirus known as COVID-19. A nasopharyngeal swab is used to collect a specimen. The swab is then placed in the processing tube.
The clinician can decide to use one of two modes – walk away or analyze now. If the “walk away” mode is used, 3 drops from the processing tube are placed on the testing device. After 10 minutes the device is inserted in the BD Veritor and the results are displayed on the screen. If the “analyze now” mode is chosen, 3 drops from the processing tube are placed on the testing device that is immediately inserted into the machine. After 10 minutes the results will be displayed on the screen.
The BD Veritor allows for point of care testing and treatment foregoing a long delay and allowing prompt action. Rapid diagnostic results, wide availability, and ease of testing with devices such as the BD Veritor Plus have proven even more valuable during this time.